Supplementary Table S3 from PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis

Authors:
  • LJLucia B. Jilaveanu
    Lucia B. Jilaveanu
  • FPFabio Parisi
    Fabio Parisi
  • MBMeaghan L. Barr
    Meaghan L. Barr
  • CZChristopher R. Zito
    Christopher R. Zito
  • WCWilliam Cruz-Munoz
    William Cruz-Munoz
  • RKRobert S. Kerbel
    Robert S. Kerbel
  • DRDavid L. Rimm
    David L. Rimm
  • MBMarcus W. Bosenberg
    Marcus W. Bosenberg
  • RHRuth Halaban
    Ruth Halaban
  • YKYuval Kluger
    Yuval Kluger
  • HKHarriet M. Kluger
    Harriet M. Kluger

Abstract
Supplementary Table S3: This table provides the results of a multivariable Cox proportional hazards analysis of PLEKHA5 and other clinical variables. PLEKHA5 was independently associated with development of early brain metastases.